GB0718434D0 - New chemical compounds - Google Patents

New chemical compounds

Info

Publication number
GB0718434D0
GB0718434D0 GB0718434A GB0718434A GB0718434D0 GB 0718434 D0 GB0718434 D0 GB 0718434D0 GB 0718434 A GB0718434 A GB 0718434A GB 0718434 A GB0718434 A GB 0718434A GB 0718434 D0 GB0718434 D0 GB 0718434D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
new chemical
new
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0718434A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
Vernalis R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vernalis R&D Ltd filed Critical Vernalis R&D Ltd
Priority to GB0718434A priority Critical patent/GB0718434D0/en
Publication of GB0718434D0 publication Critical patent/GB0718434D0/en
Priority to JP2010525422A priority patent/JP2010540422A/ja
Priority to PCT/GB2008/003173 priority patent/WO2009037463A1/en
Priority to EP20080806328 priority patent/EP2205607A1/en
Priority to US12/678,378 priority patent/US9120807B2/en
Priority to US14/803,214 priority patent/US9610290B2/en
Priority to US15/436,988 priority patent/US9920066B2/en
Priority to US15/891,618 priority patent/US10556911B2/en
Priority to US16/726,308 priority patent/US11028097B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0718434A 2007-09-21 2007-09-21 New chemical compounds Ceased GB0718434D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB0718434A GB0718434D0 (en) 2007-09-21 2007-09-21 New chemical compounds
JP2010525422A JP2010540422A (ja) 2007-09-21 2008-09-19 チエノピリミジン化合物類
PCT/GB2008/003173 WO2009037463A1 (en) 2007-09-21 2008-09-19 Thienopyrimidine compounds
EP20080806328 EP2205607A1 (en) 2007-09-21 2008-09-19 Thienopyrimidine compounds
US12/678,378 US9120807B2 (en) 2007-09-21 2008-09-19 Thienopyrimidine compounds
US14/803,214 US9610290B2 (en) 2007-09-21 2015-07-20 Thienopyrimidine compounds
US15/436,988 US9920066B2 (en) 2007-09-21 2017-02-20 Thienopyrimidine compounds
US15/891,618 US10556911B2 (en) 2007-09-21 2018-02-08 Thienopyrimidine compounds
US16/726,308 US11028097B2 (en) 2007-09-21 2019-12-24 Thienopyrimidine compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0718434A GB0718434D0 (en) 2007-09-21 2007-09-21 New chemical compounds

Publications (1)

Publication Number Publication Date
GB0718434D0 true GB0718434D0 (en) 2007-10-31

Family

ID=38670289

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0718434A Ceased GB0718434D0 (en) 2007-09-21 2007-09-21 New chemical compounds

Country Status (5)

Country Link
US (5) US9120807B2 (enExample)
EP (1) EP2205607A1 (enExample)
JP (1) JP2010540422A (enExample)
GB (1) GB0718434D0 (enExample)
WO (1) WO2009037463A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US10793636B2 (en) 2016-07-11 2020-10-06 Corvus Pharmaceuticals, Inc. Anti-CD73 antibodies
EP3675856A4 (en) 2017-08-31 2021-04-14 Corvus Pharmaceuticals, Inc. COMPOUNDS AND METHODS FOR MODULATING THE A2B ADENOSINE RECEPTOR AND A2A ADENOSINE RECEPTOR
AU2023252914A1 (en) 2022-04-13 2024-10-17 Arcus Biosciences, Inc. Combination therapy for treating trop-2 expressing cancers
WO2025137640A1 (en) 2023-12-22 2025-06-26 Gilead Sciences, Inc. Azaspiro wrn inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117878A (en) 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
GB9915437D0 (en) * 1999-07-01 1999-09-01 Cerebrus Ltd Chemical compounds III
ATE468339T1 (de) * 2001-12-20 2010-06-15 Osi Pharm Inc Pyrrolopyrimidin a2b selektive antagonistische verbindungen, deren synthese und verwendung
WO2003063800A2 (en) 2002-02-01 2003-08-07 King Pharmaceuticals Research And Development, Inc. 8-heteroaryl xanthine adenosine a2b receptor antagonists
MXPA06004789A (es) * 2003-10-31 2006-07-03 Cv Therapeutics Inc Antagonistas del receptor de adenosina a2b.
WO2007103776A2 (en) * 2006-03-02 2007-09-13 Cv Therapeutics, Inc. A2a adenosine receptor antagonists

Also Published As

Publication number Publication date
EP2205607A1 (en) 2010-07-14
US9920066B2 (en) 2018-03-20
US20200140455A1 (en) 2020-05-07
US9610290B2 (en) 2017-04-04
US20150342953A1 (en) 2015-12-03
JP2010540422A (ja) 2010-12-24
US20170291907A1 (en) 2017-10-12
US11028097B2 (en) 2021-06-08
WO2009037463A1 (en) 2009-03-26
US20180162872A1 (en) 2018-06-14
US20110118284A1 (en) 2011-05-19
US9120807B2 (en) 2015-09-01
US10556911B2 (en) 2020-02-11

Similar Documents

Publication Publication Date Title
IL202625A0 (en) New chemical compounds
GB0720126D0 (en) Chemical compounds
EP2136632A4 (en) CHEMICAL COMPOUNDS
ZA201004373B (en) Chemical compounds
IL202217A0 (en) Chemical compounds
EP2136635A4 (en) CHEMICAL COMPOUNDS
IL211744A0 (en) New chemical compounds
GB0702413D0 (en) New chemical compounds
EP2362775A4 (en) CHEMICAL COMPOUNDS
GB0619342D0 (en) New chemical compounds
EP2330909A4 (en) CHEMICAL COMPOUNDS
GB0707934D0 (en) Chemical compounds
GB0702384D0 (en) Chemical compounds
GB0718432D0 (en) New chemical compounds
GB0713602D0 (en) Chemical compounds
GB0707662D0 (en) Chemical compounds
GB0715750D0 (en) Chemical compounds
GB0718433D0 (en) New chemical compounds
GB0718434D0 (en) New chemical compounds
GB0721178D0 (en) Chemical compounds
GB0804067D0 (en) Chemical compounds
GB0619343D0 (en) New chemical compounds
GB0721850D0 (en) Chemical compounds
GB0711086D0 (en) New chemical compounds
GB0711085D0 (en) New Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)